5-CHLORO-2-(2-NAPHTHYLOXY)ANILINE
- $205 - $802.73
- Product name: 5-CHLORO-2-(2-NAPHTHYLOXY)ANILINE
- CAS: 32219-17-3
- MF: C16H12ClNO
- MW: 269.73
- EINECS:
- MDL Number:MFCD00552385
- Synonyms:5-CHLORO-2-(2-NAPHTHYLOXY)ANILINE;AKOS B034424;Benzenamine, 5-chloro-2-(2-naphthalenyloxy)-
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500MG
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0076260
- Product description5-CHLORO-2-(2-NAPHTHYLOXY)ANILINE 95.00%
- Packaging500MG
- Price$802.73
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM236722
- Product description5-Chloro-2-(naphthalen-2-yloxy)aniline 97%
- Packaging5g
- Price$611
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12083894
- Product description5-Chloro-2-(naphthalen-2-yloxy)aniline 97%
- Packaging5g
- Price$648
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number022017
- Product description5-Chloro-2-(2-naphthyloxy)aniline
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0076260 | 5-CHLORO-2-(2-NAPHTHYLOXY)ANILINE 95.00% | 500MG | $802.73 | 2021-12-16 | Buy |
Chemenu | CM236722 | 5-Chloro-2-(naphthalen-2-yloxy)aniline 97% | 5g | $611 | 2021-12-16 | Buy |
Crysdot | CD12083894 | 5-Chloro-2-(naphthalen-2-yloxy)aniline 97% | 5g | $648 | 2021-12-16 | Buy |
Matrix Scientific | 022017 | 5-Chloro-2-(2-naphthyloxy)aniline | 500mg | $205 | 2021-12-16 | Buy |
Properties
Melting point :120-121 °C(Solv: ethanol (64-17-5))
Boiling point :422.0±30.0 °C(Predicted)
Density :1.294±0.06 g/cm3(Predicted)
pka :3.29±0.10(Predicted)
Boiling point :422.0±30.0 °C(Predicted)
Density :1.294±0.06 g/cm3(Predicted)
pka :3.29±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|